The private capital files.
Who holds what, what it's worth, and who's actually returning capital: India's capital providers, venture to sovereign, tracked position-by-position.
Market pulse · the water these firms swim in
The India venture backdrop as of July 2026: sourced, with the series conflicts disclosed rather than averaged away.
The broader private-capital market is not collapsing, but it is no longer giving every GP an easy beta tailwind
Deal count rose 7% YoY even as capital fell: more selective cheque sizing, not a dead market
Narrower tech-only series disagree: Tracxn $10.5bn (-17%), Nasscom $9.1bn (+23%): different universes
VCs realised ~$2bn from IPO exits in 2025, +30% YoY; 8 of 15 new-age listings now below issue
Peak XV $1.3bn, Nexus $700M, Accel $650M, A91 $665M lead the restock
Where discounted: avg 19% (±9%): the GP-led liquidity market is functioning
The one unambiguous H1 2026 growth sector; every GP now claims AI, but only a few have DPI-compatible AI exposure
Razorpay filed confidentially; Zepto filed updated papers for a July-targeted listing: the liquidity calendar is now live
The league table
Ranked by GW GP Score: our research opinion on franchise strength, weighted hardest on whether LPs actually get paid. Equity investors first; the credit, growth-buyout and sovereign desks, different asset classes scored through their own lenses, sit below. Compare any two →
| Franchise | AUM | Latest fund | Unicorns | Exits · 24mo | GW GP Score | Outlook | Conf. |
|---|---|---|---|---|---|---|---|
| 01Prosus Ventures Growth → listed · ecosystem + AI · $100M+ cheques | $7bn+ deployed in digital India · balance sheet | $7bn+ deployed · evergreen | 6 | 2 | 79G2 Strong | Positive | High |
| 02Info Edge Ventures Seed → growth · consumer, AI, deeptech · Temasek co-anchor | ₹4,900 Cr deployed · marked ₹41,300 Cr (Mar 2026) | >₹2,000 Cr expected (w/ Temasek) · 2025 | 4 | 1 | 79G2 Strong | Positive | High |
| 03WestBridge Capital Series A → IPO and beyond · crossover | $7bn evergreen (firm); ~$10bn India AUM (2022 press reporting) | $7bn · evergreen | 7 | 3 | 78G2 Strong | Stable | Medium |
| 04Peak XV Partners Seed (Surge) / Venture / Growth · India + APAC | $10bn+ · 16 funds | $1.3bn combined · 2026 | 40 | 4 | 77G2 Strong | Stable | Medium |
| 05Nexus Venture Partners Inception / Seed / Series A · India + US | ~$3.2bn | $700M · 2025 | 8 | 4 | 76G2 Strong | Positive | Medium |
| 06Accel India Pre-seed (Atoms) / Seed / Series A | ~$3bn committed across 8 India funds | $650M · 2025 | 7 | 4 | 76G2 Strong | Positive | Medium |
| 07Bessemer India Early-stage · $5-40M cheques | $570M India-dedicated ($220M Fund I + $350M Fund II) + global-fund history | $350M · 2025 | 4 | 4 | 76G2 Strong | Positive | Medium |
| 08Stellaris Venture Partners Seed / Series A · concentrated (25-30/fund) | >$600M across 3 funds | $300M · 2024 | 1 | 2 | 75G2 Strong | Positive | Medium |
| 09Fireside Ventures Early + growth consumer · $1-12M cheques | ~$650M (₹5,300 Cr) | $253M (₹2,265 Cr) · 2025 | 2 | 2 | 75G2 Strong | Positive | Medium |
| 10Premji Invest Growth + early-stage tech + public equities · India + US | $10bn+ evergreen | $10bn+ · 2006 | 4 | 2 | 75G2 Strong | Stable | Medium |
| 11Endiya Partners Seed · product/deeptech · India-to-global | ~$200M cumulative (E) | $100M · 2025 | 1 | 2 | 75G2 Strong | Positive | Medium |
| 12Elevation Capital Seed–Growth + late-stage/pre-IPO (Holdings) | $3.5bn+ | $400M · 2025 | 5 | 5 | 74G2 Strong | Stable | Medium |
| 133one4 Capital Seed / Series A | $750M+ | ~$225M target · in market | 4 | 3 | 74G2 Strong | Positive | Medium |
| 14A91 Partners Growth / Series B-C · $10-50M cheques | ~$1.57bn raised across 3 funds | $665M · 2025 | 2 | 2 | 73G2 Strong | Stable | Medium |
| 15SoftBank Vision Fund Late-stage · harvest mode → AI restart ($20-25M cheques) | $10.6bn deployed India · $7.2bn realised | $10.6bn India · 2017-2021 | 8 | 4 | 71G2 Strong | Developing | Medium |
| 16Lightspeed India Seed–Growth · AI, deeptech, consumer | ~$1.1bn India-dedicated + global-pool access ($9bn, Dec 2025) | $9bn+ · 2025 | 8 | 2 | 70G2 Strong | Developing | Medium |
| 17Chiratae Ventures Seed / Series A / Series B · deeptech tilt | $1.3bn across 7 funds | $150M closed / $350M target · 2025 | 8 | 4 | 69G3 Sound | Developing | Medium |
| 18India Quotient Pre-seed / Seed · ₹1-15 Cr · consumer-first | ~$250M (E) | $129M · 2025 | 1 | 3 | 69G3 Sound | Stable | Medium |
| 19Speciale Invest Pre-seed/Seed deeptech + growth vehicle · ₹7-10 Cr entries | ~₹1,130 Cr closed (~$135M) + ₹1,400 Cr raising | ₹1,400 Cr target · raising | 0 | 1 | 68G3 Sound | Positive | Low |
| 20Blume Ventures Pre-seed / Seed / Series A | ~$900M | $175M first close · 2025 | 6 | 3 | 67G3 Sound | Stable | Medium |
| 21DSG Consumer Partners Seed → early consumer · first cheques up to $5M | $300M+ | $114M · 2023 | 0 | 1 | 66G3 Sound | Stable | Medium |
| 22Kenro Capital Growth secondaries · $20-30M cheques · India + SEA | Undisclosed · >$120M deployed in year one | Undisclosed · 2024 | 1 | 1 | 65G3 Sound | Positive | Low |
| 23Together Fund Seed / Series A · $1-10M · AI-native only · US-India corridor | >$200M (firm claims $250M+) | $150M target · 2023 | 0 | 1 | 65G3 Sound | Positive | Low |
| 24Prime Venture Partners Seed · $2-4M first cheques · fintech, AI, SaaS | >$200M deployed · ~$350M raised (E) | $100M · 2025 | 0 | 0 | 65G3 Sound | Stable | Medium |
| 25Z47 Seed / Early / Early-growth | ~$1.5-3.5bn (managed vs firm-claim: disputed basis) | $300-400M target · raising | 11 | 4 | 62G3 Sound | Negative | Medium |
| 26General Catalyst India Seed → growth + company creation | $5bn India pledge over 5 years ($43bn global AUM) | $5bn / 5 years · 2026 | 3 | 0 | 62G3 Sound | Developing | Low |
| 27pi Ventures Seed / Series A · AI + deeptech infra · $250K-3M | ~₹927 Cr (~$115M) across two funds | ₹702 Cr · 2022 | 0 | 2 | 61G3 Sound | Developing | Low |
| 28Oister Global Late-stage secondaries · pre-IPO 12-24 months | ACE series: ₹400 Cr (II) + ₹500 Cr (III) · JV target $500M (status unclear) | ₹500 Cr (₹250 Cr + greenshoe) · 2026 | 1 | 1 | 60G3 Sound | Developing | Low |
| 29Tiger Global Crossover · harvest + selective follow-ons | ~$2-4bn active India positions (E) · PIP 16 ~$2.2bn global | ~$2.2bn · 2025 | 12 | 3 | 60G3 Sound | Negative | Medium |
| 30Arkam Ventures Seed–Series B · $1-5M cheques · middle-India + applied AI | ~$256M (Fund I $106M + Fund II target $150M, open) | $150M target (cut from $180M) · open | 3 | 0 | 58G3 Sound | Developing | Low |
| 31Creaegis Growth · $25-40M lead cheques · 12-15 positions | $425M maiden fund (~deployed) | $425M · 2023 | 0 | 0 | 58G3 Sound | Developing | Low |
| 32Kalaari Capital Pre-seed / Seed · AI-first cheques $1-6M | ~$650M | up to $200M (Reliance/Jio anchor) · 2021 | 8 | 3 | 55G3 Sound | Negative | Medium |
| 33Northpoint Capital Seed / Series A · $1-8M cheques · 15-20 positions | $150M · Fund I closed | $150M · 2025 | 0 | 0 | 54G4 Adequate | Developing | Low |
| 34Mettle Capital Series A/B + selective seed · enterprise AI, deeptech, consumer | Pre-close · $350-400M target | $350-400M target · raising | 0 | 0 | 43G5 Speculative | Developing | Low |
The private credit desk
Venture debt and growth credit: the counterparties every equity book above calls when it wants runway without a repricing. Scored on the same five factors read through a credit lens: realisation means repayments and recoveries, not OFS multiples.
| Platform | Commitments / AUM | Latest vehicle | Borrower unicorns | Events · 24mo | GW GP Score | Outlook | Conf. |
|---|---|---|---|---|---|---|---|
| 01Trifecta Capital Venture debt (₹25-30 Cr avg) + growth equity crossover | ₹5,400 Cr raised · ₹8,700 Cr deployed (incl. recycled) | ₹2,000 Cr target (incl. greenshoe) · raising | 30 | 2 | 75G2 Strong | Positive | Medium |
| 02Alteria Capital Venture debt + short-duration credit · up to ₹200 Cr tickets | ₹4,350-4,500 Cr (~$540M) · ₹7,500+ Cr deployed | ₹1,550 Cr · 2024 | 16 | 2 | 71G2 Strong | Stable | Low |
| 03InnoVen Capital Later-stage venture debt · larger tickets, IPO-bound credits | $850M+ deployed India · NBFC + AIF (₹740 Cr first close) | n.d. (~$150M AUM, E) · 2008- | 35 | 1 | 69G3 Sound | Stable | Medium |
| 04BlackSoil Alternative credit · venture + SME/impact · ₹5-30 Cr tickets | ₹1,918 Cr assets · ₹14,000 Cr cumulative disbursed (merged) | ₹1,918 Cr assets · 2016- | 11 | 1 | 68G3 Sound | Positive | Medium |
| 05Stride Ventures Venture debt / growth credit · $10-15M tickets · India + GCC + UK | $1.6bn+ credit enabled · ~$415M across closed funds | $300M target · raising | 12 | 2 | 66G3 Sound | Developing | Low |
The growth & buyout desk
Mid-market PE: control deals, continuation vehicles and staged public-market exits. Where the venture books above sell, these desks often buy.
| Firm | AUM / raised | Latest vehicle | Unicorn-class holds | Events · 24mo | GW GP Score | Outlook | Conf. |
|---|---|---|---|---|---|---|---|
| 01Kedaara Capital Control + minority growth · $100M+ · operating-heavy (CD&R model) | $6bn+ across four funds | $1.74bn · 2024 | 5 | 5 | 81G2 Strong | Positive | Medium |
| 02ChrysCapital Buyouts + growth minority · industrials, healthcare, services | ~$8.5bn raised · $5.5bn deployed · $7.8bn realised | $2.2bn · 2025 | 4 | 3 | 80G2 Strong | Positive | Medium |
| 03True North Control / significant-minority mid-market · FS, healthcare, consumer + private credit | ~$3bn+ raised across six PE funds + credit platform | $650M + ₹150M INR sleeve target · raising | 1 | 4 | 75G2 Strong | Stable | Medium |
| 04Multiples Growth → control buyouts · $50-150M · FS, consumer, tech, healthcare | $1.8bn AUM · ~$3bn raised incl. CV | $430M · 2025 | 4 | 2 | 73G2 Strong | Stable | Medium |
The sovereign & crossover desk
State-linked permanent capital investing directly in Indian private markets: the counterparties on the other side of half the cap tables above.
| Investor | India exposure | Latest activity | Unicorn-class holds | Events · 24mo | GW GP Score | Outlook | Conf. |
|---|---|---|---|---|---|---|---|
| 01Temasek (India) Growth minority → control · consumer, healthcare, financial services, green | ~$50bn India book (Mar 2025) · $10bn/3yr commitment | ~$50bn India NPV · evergreen | 8 | 3 | 82G2 Strong | Positive | Medium |
| 02GIC (India) Public + private · FS, infra, real assets, late-stage tech | India book est. $35-50bn (E) · ~$20bn financial services (stated) | Group ~$936bn (R); India undisclosed · evergreen | 5 | 2 | 73G2 Strong | Stable | Low |
| 03ADIA (India) Direct stakes + platform JVs + anchor books · FS, consumer, healthcare, renewables | India privates est. $15-20bn+ (E) · $4-5bn GIFT vehicle | $4-5bn planned · 2024 | 4 | 1 | 70G2 Strong | Stable | Low |
Fund analytics screener · LP decision table
One screen for re-up quality, cash conversion, fund status, mark drift, partner churn and next liquidity. Values are computed from public dossiers and labelled estimates where underlying fund-level data is not public.
| Firm | Re-up verdict | Latest fund | Cash conversion | Exit events | IPO queue | Mark drift | Partner churn | Concentration | Evidence |
|---|---|---|---|---|---|---|---|---|---|
| Prosus Ventures GW 79 · Positive | Strong re-up 81/100 | $7bn+ deployed · evergreen Mid-cycle | Visible but incomplete | 2 | 5 | Positive mark drift 11/0/1 | Stable bench 0 signals | High concentration Consumer & Commerce (56%) | Current High |
| Info Edge Ventures GW 79 · Positive | Conditional positive 75/100 | >₹2,000 Cr expected (w/ Temasek) · 2025 Fresh dry powder | Visible but incomplete | 1 | 3 | Constructive 5/3/2 | Stable bench 0 signals | Moderate concentration Consumer & Commerce (42%) | Current High |
| WestBridge Capital GW 78 · Stable | Strong re-up 81/100 | $7bn · evergreen Mid-cycle | High cash conversion | 3 | 3 | Positive mark drift 7/6/0 | Stable bench 0 signals | Moderate concentration Consumer & Commerce (34%) | Current Medium |
| Peak XV Partners GW 77 · Stable | Strong re-up 76/100 | $1.3bn combined · 2026 Fresh dry powder | High cash conversion | 4 | 5 | Positive mark drift 11/3/1 | Watch 1 signals | Moderate concentration AI (30%) | Current Medium |
| Nexus Venture Partners GW 76 · Positive | Strong re-up 76/100 | $700M · 2025 Fresh dry powder | High cash conversion | 4 | 3 | Constructive 7/6/1 | Watch 1 signals | Diversified AI (28%) | Current Medium |
| Accel India GW 76 · Positive | Strong re-up 82/100 | $650M · 2025 Fresh dry powder | Visible but incomplete | 4 | 1 | Positive mark drift 8/2/0 | Stable bench 0 signals | Diversified Consumer & Commerce (24%) | Current Medium |
| Bessemer India GW 76 · Positive | Strong re-up 82/100 | $350M · 2025 Fresh dry powder | High cash conversion | 4 | 2 | Positive mark drift 8/1/1 | Stable bench 0 signals | Diversified Fintech (26%) | Current Medium |
| Stellaris Venture Partners GW 75 · Positive | Strong re-up 79/100 | $300M · 2024 Mid-cycle | Visible but incomplete | 2 | 2 | Positive mark drift 5/4/0 | Stable bench 0 signals | Diversified AI (26%) | Recent Medium |
| Fireside Ventures GW 75 · Positive | Strong re-up 84/100 | $253M (₹2,265 Cr) · 2025 Fresh dry powder | High cash conversion | 2 | 3 | Positive mark drift 8/1/0 | Stable bench 0 signals | High concentration Consumer & Commerce (74%) | Recent Medium |
| Premji Invest GW 75 · Stable | Strong re-up 79/100 | $10bn+ · 2006 Aging flagship | Visible but incomplete | 2 | 2 | Positive mark drift 6/2/0 | Stable bench 0 signals | Moderate concentration Consumer & Commerce (34%) | Stale Medium |
| Endiya Partners GW 75 · Positive | Strong re-up 80/100 | $100M · 2025 Fresh dry powder | High cash conversion | 2 | 0 | Positive mark drift 6/2/0 | Stable bench 0 signals | Diversified SaaS & Dev Tools (28%) | Current Medium |
| Elevation Capital GW 74 · Stable | Conditional positive 75/100 | $400M · 2025 Fresh dry powder | High cash conversion | 5 | 2 | Positive mark drift 9/3/2 | Watch 1 signals | Moderate concentration Consumer & Commerce (42%) | Recent Medium |
| 3one4 Capital GW 74 · Positive | Conditional positive 75/100 | ~$225M target · in market Raise pressure | High cash conversion | 3 | 2 | Constructive 4/5/2 | Stable bench 0 signals | Diversified Fintech (22%) | Current Medium |
| A91 Partners GW 73 · Stable | Strong re-up 79/100 | $665M · 2025 Fresh dry powder | High cash conversion | 2 | 5 | Positive mark drift 7/4/0 | Stable bench 0 signals | Moderate concentration Consumer & Commerce (44%) | Current Medium |
| SoftBank Vision Fund GW 71 · Developing | Conditional positive 75/100 | $10.6bn India · 2017-2021 Aging flagship | High cash conversion | 4 | 6 | Constructive 6/5/1 | Stable bench 0 signals | High concentration Consumer & Commerce (52%) | Current Medium |
| Lightspeed India GW 70 · Developing | Conditional positive 67/100 | $9bn+ · 2025 Fresh dry powder | Visible but incomplete | 2 | 7 | Positive mark drift 8/3/2 | Stable bench 0 signals | Diversified Consumer & Commerce (26%) | Current Medium |
| Chiratae Ventures GW 69 · Developing | Conditional positive 70/100 | $150M closed / $350M target · 2025 Fresh dry powder | High cash conversion | 4 | 3 | Constructive 5/2/2 | Stable bench 0 signals | Moderate concentration Consumer & Commerce (36%) | Current Medium |
| India Quotient GW 69 · Stable | Conditional positive 73/100 | $129M · 2025 Fresh dry powder | High cash conversion | 3 | 3 | Mixed 3/2/3 | Stable bench 0 signals | High concentration Consumer & Commerce (54%) | Current Medium |
| Speciale Invest GW 68 · Positive | Conditional positive 70/100 | ₹1,400 Cr target · raising Raise pressure | Paper-heavy | 1 | 1 | Positive mark drift 5/1/0 | Stable bench 0 signals | High concentration Deeptech & Space (62%) | Recent Low |
| Blume Ventures GW 67 · Stable | Conditional positive 72/100 | $175M first close · 2025 Fresh dry powder | Visible but incomplete | 3 | 3 | Positive mark drift 11/4/1 | Stable bench 0 signals | Diversified Consumer & Commerce (26%) | Current Medium |
| DSG Consumer Partners GW 66 · Stable | Conditional positive 75/100 | $114M · 2023 Mid-cycle | Visible but incomplete | 1 | 1 | Positive mark drift 6/1/0 | Stable bench 0 signals | High concentration Consumer & Commerce (84%) | Current Medium |
| Kenro Capital GW 65 · Positive | Conditional positive 71/100 | Undisclosed · 2024 Mid-cycle | Paper-heavy | 1 | 1 | Positive mark drift 3/0/0 | Stable bench 0 signals | High concentration Consumer & Commerce (60%) | Current Low |
| Together Fund GW 65 · Positive | Diligence-heavy 64/100 | $150M target · 2023 Mid-cycle | Paper-heavy | 1 | 1 | Positive mark drift 5/3/0 | Stable bench 0 signals | High concentration AI (56%) | Current Low |
| Prime Venture Partners GW 65 · Stable | Diligence-heavy 62/100 | $100M · 2025 Fresh dry powder | Thin cash trail | 0 | 2 | Constructive 4/3/1 | Stable bench 0 signals | Moderate concentration Fintech (40%) | Recent Medium |
| Z47 GW 62 · Negative | Diligence-heavy 60/100 | $300-400M target · raising Raise pressure | High cash conversion | 4 | 7 | Constructive 6/4/2 | Watch 1 signals | Moderate concentration Fintech (32%) | Current Medium |
| General Catalyst India GW 62 · Developing | Diligence-heavy 55/100 | $5bn / 5 years · 2026 Fresh dry powder | Thin cash trail | 0 | 2 | Positive mark drift 6/2/0 | Watch 1 signals | Moderate concentration Consumer & Commerce (30%) | Current Low |
| pi Ventures GW 61 · Developing | Diligence-heavy 61/100 | ₹702 Cr · 2022 Aging flagship | Paper-heavy | 2 | 2 | Positive mark drift 3/3/0 | Watch 1 signals | Moderate concentration AI (30%) | Current Low |
| Oister Global GW 60 · Developing | Diligence-heavy 64/100 | ₹500 Cr (₹250 Cr + greenshoe) · 2026 Fresh dry powder | Paper-heavy | 1 | 2 | Positive mark drift 4/1/0 | Stable bench 0 signals | Moderate concentration Consumer & Commerce (40%) | Current Low |
| Tiger Global GW 60 · Negative | Conditional positive 67/100 | ~$2.2bn · 2025 Fresh dry powder | High cash conversion | 3 | 5 | Positive mark drift 8/0/2 | Stable bench 0 signals | Moderate concentration Consumer & Commerce (40%) | Current Medium |
| Arkam Ventures GW 58 · Developing | Weak / wait 53/100 | $150M target (cut from $180M) · open Mid-cycle | Thin cash trail | 0 | 2 | Positive mark drift 8/1/1 | Stable bench 0 signals | Moderate concentration Fintech (40%) | Current Low |
| Creaegis GW 58 · Developing | Weak / wait 54/100 | $425M · 2023 Mid-cycle | Thin cash trail | 0 | 1 | Constructive 4/2/1 | Stable bench 0 signals | Moderate concentration Consumer & Commerce (30%) | Recent Low |
| Kalaari Capital GW 55 · Negative | Weak / wait 54/100 | up to $200M (Reliance/Jio anchor) · 2021 Aging flagship | Paper-heavy | 3 | 3 | Mixed 3/4/4 | Stable bench 0 signals | Moderate concentration Consumer & Commerce (44%) | Current Medium |
| Northpoint Capital GW 54 · Developing | Diligence-heavy 57/100 | $150M · 2025 Fresh dry powder | Thin cash trail | 0 | 0 | Positive mark drift 1/0/0 | Stable bench 0 signals | High concentration Consumer & Commerce (100%) | Current Low |
| Mettle Capital GW 43 · Developing | Weak / wait 36/100 | $350-400M target · raising Raise pressure | Thin cash trail | 0 | 0 | Mixed 0/0/0 | Stable bench 0 signals | Diversified n.d. | Current Low |
Catalyst tape · source to score pressure
The latest public datapoints translated into research pressure: which GP it hits, why it matters, and what would move the score. This is the private-market equivalent of an earnings-calendar shock table.
SEBI approved a ~₹8,000 Cr fresh issue plus an OFS of ~4.32 Cr shares; Temasek's control asset now guides to a late-July/early-August 2026 listing at a reported $10-13bn valuation.
Score pressurePositive for Temasek's exit-realisation dimension once the listing prices; India's biggest-ever healthcare IPO converts a long-held control position into a monetisation engine.
WatchPrice band, listing date, and post-listing float behaviour of India's largest private hospital platform.
The broad private-capital backdrop is selective rather than euphoric; fundraising and mark support now need firm-specific proof.
Score pressureRaises the bar for weak-DPI managers and stale flagship vehicles; rewards funds with fresh closes or visible exits.
WatchSeparate broad PE-VC softness from venture AI strength before changing sector-positioning scores.
Anand Rathi puts Zepto's unlisted price at ₹38-40, down from ₹50-52 in March 2026, and estimates it needs ~3,000 daily orders/store (vs ~1,500-1,800 for rivals) to reach profitability, naming Eternal/Blinkit the 'safer' quick-commerce trade instead.
Score pressureSoftens near-term DPI expectations for Zepto-heavy books; watch whether the IPO prices through the caution or the brokerage view holds.
WatchFinal DRHP pricing, whether the July IPO-wave listing (~₹8,000 Cr) confirms or slips, and any second brokerage view corroborating or disputing the profitability bar.
Mohalla Tech turned operationally profitable in Q1 FY27, with an annualised revenue run-rate of ~₹1,400 Cr growing 30%+, driven by micro-drama content, and is now guiding to a ~$400M listing next year.
Score pressureFirst positive signal on the long-marked-down ShareChat position since the 2021 peak; still a year-plus from an actual print.
WatchAny priced round ahead of the IPO that would reset the residual mark, and continued profitability through FY27.
$676M across 57 AI deals makes AI the cleanest growth pocket in the current venture tape.
Score pressureSupports sector-positioning scores only where AI exposure is backed by credible entry price, ownership and exit path.
WatchDo not reward AI labels without DPI-compatible positions; paper-heavy AI books stay on proof watch.
Dream Money, the mutual-funds/digital-gold/lending arm launched Aug 2025 to offset the real-money-gaming ban's revenue hit, is closing by 2026-07-30; the company frames it as refocusing on its DreamStreet stock-broking unit.
Score pressureConfirms the Dream11 impairment thesis is still deepening rather than recovering across every book holding the position.
WatchAny RMG-ban litigation or legislative movement; DreamStreet traction as the stated pivot.
Chiswick Investment Pte Ltd sold 11.03% of Genus Power for ₹955.6 Cr, cutting the stake from 15.11% to 4.08%, resolving the prior (R) attribution with a sourced, larger figure.
Score pressurePositive, concrete realisation event for GIC's thinly-disclosed book; the confirmed attribution itself is a data-quality upgrade regardless of the sale's size.
WatchWhether GIC exits the residual 4.08% and how the desk's other public-market stakes (IRB InvIT, Euler Motors) trend.
The expected ₹5,000-6,000 Cr issue is the bellwether fintech realisation event for the 2026-27 IPO queue.
Score pressurePositive for holders if valuation and OFS quantum hold; negative if the listing clears materially below the $7.5B private peak.
WatchDRHP details, OFS participants, valuation range and post-listing block-sale behaviour.
Catalyst attribution · who benefits, who is under pressure
India PE-VC value down 5% YoY in H1 CY2026
Indian AI startup funding >4x YoY in H1 2026
Razorpay files confidential DRHP
India PE-VC value down 5% YoY in H1 CY2026
India PE-VC value down 5% YoY in H1 CY2026
India PE-VC value down 5% YoY in H1 CY2026
India PE-VC value down 5% YoY in H1 CY2026
India PE-VC value down 5% YoY in H1 CY2026
Re-rating watch · what would move the GP score
A score is only useful if the reader knows what can change it. This board converts fresh catalysts, DPI evidence, fund status, source freshness and partner churn into upgrade/downgrade bias.
| Firm | Current score | Bias | Pressure | Upgrade trigger | Downgrade trigger | Next review |
|---|---|---|---|---|---|---|
| General Catalyst India Developing outlook · Low conf. | 62 | Downgrade watch | -8 to -6 GW estimate | Senior India investing hires to replace the Mohan gap. | Another senior departure or weak attribution on the next fund's named partners. | First large post-pledge deployments: none individually verified since Feb 2026. |
| Peak XV Partners Stable outlook · Medium conf. | 77 | Upgrade watch | +6 to +7 GW estimate | Meesho liquidity clears with credible OFS/block-sale evidence. | Another senior departure or weak attribution on the next fund's named partners. | Rajan Anandan status: conflicting public signals as of Jul 2026. |
| Prosus Ventures Positive outlook · High conf. | 79 | Upgrade watch | +5 to +6 GW estimate | Swiggy liquidity clears with credible OFS/block-sale evidence. | Rapido IPO preparation: the book's next flagship listing. | Jar ~$50M round, in talks, unconfirmed. |
| A91 Partners Stable outlook · Medium conf. | 73 | Upgrade watch | +5 to +6 GW estimate | Go Digit liquidity clears with credible OFS/block-sale evidence. | River EV round (~$80M at ~$200M, Feb 2026 talks): unconfirmed as of Jul 2026. | Atomberg DRHP (~Jul 2026 target) and FY27 listing: the next conveyor event. |
| Tiger Global Negative outlook · Medium conf. | 60 | Upgrade watch | +5 to +6 GW estimate | PhonePe liquidity clears with credible OFS/block-sale evidence. | GAAR ruling fallout: appeals, settlements, structure migrations. | PhonePe IPO revival: deferred Mar 2026; Tiger's full exit rides on it. |
| Creaegis Developing outlook · Low conf. | 58 | Downgrade watch | -6 to -4 GW estimate | Fund II launch and size. | IPO/secondary window fails to convert paper marks into distributions. | Medikabazaar arbitration outcome (₹278.7 Cr claim). |
| WestBridge Capital Stable outlook · Medium conf. | 78 | Upgrade watch | +4 to +5 GW estimate | PhysicsWallah liquidity clears with credible OFS/block-sale evidence. | Vedantu IPO ($100-150M at $500-600M reported): edtech markdown print. | Rapido IPO ambitions: a listing would mark the cohort's largest single position. |
| Accel India Positive outlook · Medium conf. | 76 | Upgrade watch | +4 to +5 GW estimate | Zetwerk liquidity clears with credible OFS/block-sale evidence. | Risk-factor wording, regulator follow-up and any valuation discount embedded in the final offer. | Mid-vintage (2014/2017) DPI repair: next leaked or disclosed print vs the 0.13-0.15x Nov 2024 snapshot. |
| Bessemer India Positive outlook · Medium conf. | 76 | Upgrade watch | +4 to +5 GW estimate | Perfios liquidity clears with credible OFS/block-sale evidence. | Perfios IPO (~$500M at ~$2bn target): the book's biggest pending realisation. | Sarvam Series B final size and formal lead designation ($234M first close of ~$300M; press conflicting). |
| Endiya Partners Positive outlook · Medium conf. | 75 | Upgrade watch | +4 to +5 GW estimate | Separate broad PE-VC softness from venture AI strength before changing sector-positioning scores. | Cure.fit IPO-track mention: single-source, verify. | Kissht post-listing performance and Endiya's residual management. |
Evidence ledger · source quality control
The weakest evidence files first. Primary sources, dated 2025-26 material and low-confidence fields determine whether a GP score is publication-ready or due for source work.
| Firm | Evidence score | Source mix | Freshness | Latest source | Gap | Refresh action |
|---|---|---|---|---|---|---|
| Northpoint Capital Low dossier confidence | 14 Evidence-risk file | 0P · 3S · 1E 0% primary | Current 2026 | Entrackr: Liquidnitro $19.1M Series A (Jan 2026) | No primary source structured. | Find a filing, official firm disclosure, regulator table or LP document before next score action. |
| Mettle Capital Low dossier confidence | 14 Evidence-risk file | 0P · 3S · 1E 0% primary | Current 2026 | Inc42: Mettle targets $350-400M (May 2026) | No primary source structured. | Find a filing, official firm disclosure, regulator table or LP document before next score action. |
| Creaegis Low dossier confidence | 16 Evidence-risk file | 1P · 3S · 1E 20% primary | Recent 2025 | Entrackr: GIVA ₹530 Cr Series C (Jun 2025) | Low-confidence fields: Exit data, Portfolio data, Team data, Performance proxy. | Upgrade Exit data evidence before changing the score. |
| Speciale Invest Low dossier confidence | 19 Evidence-risk file | 0P · 4S · 1E 0% primary | Recent 2025 | Inc42: Fund III ₹600 Cr close (Aug 2025) | No primary source structured. | Find a filing, official firm disclosure, regulator table or LP document before next score action. |
| Oister Global Low dossier confidence | 21 Evidence-risk file | 0P · 3S · 1E 0% primary | Current 2026 | Inc42: ACE Fund III launch ₹500 Cr (May 2026) | No primary source structured. | Find a filing, official firm disclosure, regulator table or LP document before next score action. |
| Premji Invest Medium dossier confidence | 22 Evidence-risk file | 2P · 2S · 1E 40% primary | Stale 2024 | Business Standard: more money into AI on $10bn base (Apr 2024) | No 2025-26 source label structured. | Refresh with a dated 2025-26 source before relying on current score direction. |
| Kenro Capital Low dossier confidence | 28 Evidence-risk file | 1P · 3S · 1E 20% primary | Current 2026 | Entrackr: GIVA Series C extension (Feb 2026) | Low-confidence fields: Exit data, Portfolio data, Team data, Performance proxy. | Upgrade Exit data evidence before changing the score. |
| Prime Venture Partners Medium dossier confidence | 38 Evidence-risk file | 0P · 4S · 1E 0% primary | Recent 2025 | Entrackr: Fund V $100M close (Mar 2025) | No primary source structured. | Find a filing, official firm disclosure, regulator table or LP document before next score action. |
| Arkam Ventures Low dossier confidence | 42 Evidence-risk file | 2P · 3S · 1E 33% primary | Current 2026 | DealStreetAsia: NIIF in talks (May 2026) | Low-confidence fields: Exit data, Team data, Performance proxy. | Upgrade Exit data evidence before changing the score. |
| General Catalyst India Low dossier confidence | 45 Evidence-risk file | 1P · 4S · 1E 17% primary | Current 2026 | TechCrunch: GC commits $5bn to India (Feb 2026) | Low-confidence fields: Exit data, Performance proxy. | Upgrade Exit data evidence before changing the score. |
| Fireside Ventures Medium dossier confidence | 48 Evidence-risk file | 0P · 5S · 1E 0% primary | Recent 2025 | Inc42: Fund IV $253M close (Dec 2025) | No primary source structured. | Find a filing, official firm disclosure, regulator table or LP document before next score action. |
| Stellaris Venture Partners Medium dossier confidence | 49 Evidence-risk file | 1P · 3S · 1E 20% primary | Recent 2025 | Business Standard: consumer, AI, deeptech focus (Sep 2025) | Low-confidence fields: Performance proxy. | Upgrade Performance proxy evidence before changing the score. |
Research committee tape · where judgment should go first
A ranked tape of live GP questions, not a news feed. Priority rises when current sources, liquidity events, partner churn, fundraise risk or unusual DPI evidence make the next datapoint decision-relevant.
Diligence agenda · what can change the view
A research desk should show its open questions. This queue ranks the files where new filings, fund-close reports, OFS tables, partner moves or weak evidence can change the GP score fastest.
Sector crowding · who owns which theme
Share of each venture-equity book by sector (GW estimate): credit, growth and sovereign desks are excluded so the crowding read stays like-for-like. Deep red = concentration. Read a column before entering a theme: it's your competition map; read a row to see a franchise's bet.
| Franchise | AI | Fintech | Consumer & Commerce | SaaS & Dev Tools | Deeptech & Space | Healthcare | EV & Climate | Logistics & Infra |
|---|---|---|---|---|---|---|---|---|
| Nexus Venture Partners | 28% | 10% | 20% | 24% | 2% | 4% | · | 12% |
| Elevation Capital | 12% | 24% | 42% | 10% | · | 4% | 2% | 6% |
| 3one4 Capital | 14% | 22% | 22% | 14% | 8% | 8% | 12% | · |
| Blume Ventures | 10% | 16% | 26% | 18% | 10% | 8% | 12% | · |
| Peak XV Partners | 30% | 20% | 22% | 12% | 6% | 4% | 2% | 4% |
| Accel India | 22% | 20% | 24% | 16% | 10% | 4% | · | 4% |
| Lightspeed India | 26% | 14% | 26% | 10% | 14% | · | 4% | 6% |
| A91 Partners | 6% | 18% | 44% | 14% | 2% | 6% | 2% | 8% |
| Stellaris Venture Partners | 26% | 12% | 26% | 16% | 2% | 12% | 6% | · |
| Fireside Ventures | 4% | · | 74% | · | · | 18% | · | 4% |
| Z47 | 16% | 32% | 26% | 10% | 2% | 4% | · | 10% |
| Kalaari Capital | 22% | 12% | 44% | 4% | 6% | · | 4% | 8% |
| Chiratae Ventures | 22% | 10% | 36% | 6% | 16% | 10% | · | · |
| WestBridge Capital | 10% | 24% | 34% | 12% | · | 10% | 4% | 6% |
| General Catalyst India | 12% | 10% | 30% | · | 22% | 20% | 6% | · |
| Bessemer India | 20% | 26% | 20% | 10% | · | 22% | · | 2% |
| Kenro Capital | · | 40% | 60% | · | · | · | · | · |
| Northpoint Capital | · | · | 100% | · | · | · | · | · |
| Mettle Capital | · | · | · | · | · | · | · | · |
| Oister Global | · | 20% | 40% | 20% | · | · | · | 20% |
| Prosus Ventures | 8% | 26% | 56% | · | · | 6% | · | 4% |
| SoftBank Vision Fund | 4% | 18% | 52% | 6% | · | · | 8% | 12% |
| Tiger Global | · | 34% | 40% | 8% | 4% | · | · | 14% |
| Arkam Ventures | 18% | 40% | 16% | 10% | 8% | · | · | 8% |
| Together Fund | 56% | · | · | 28% | 8% | 8% | · | · |
| Info Edge Ventures | 18% | 14% | 42% | · | 14% | 6% | · | 6% |
| Premji Invest | 18% | 28% | 34% | 8% | · | 6% | · | 6% |
| Creaegis | · | 28% | 30% | · | · | 28% | · | 14% |
| India Quotient | · | 12% | 54% | 16% | 6% | 8% | · | 4% |
| Endiya Partners | 12% | 16% | · | 28% | 24% | 20% | · | · |
| Prime Venture Partners | 10% | 40% | 20% | 20% | · | 10% | · | · |
| Speciale Invest | 14% | · | · | 10% | 62% | 14% | · | · |
| pi Ventures | 30% | · | · | 6% | 28% | 22% | 14% | · |
| DSG Consumer Partners | · | · | 84% | · | · | 12% | · | 4% |
Cross-reference: sector dossiers for the fundamentals behind each column, and the Capital Cycle Clock for where the cycle sits.
Contested positions · where the books overlap
Companies held by two or more tracked capital providers: computed from the position books. Top 12 of 76 shown; each holder's 12-mo signal shows whether the firms even agree on the mark. View all 76 →
Computed from tracked (representative) books, so overlap is understated, not overstated (GW estimate).
The shadow pipeline · who gets paid next
Tracked-book companies queued for the 2026-27 listing window. This is the DPI calendar: each print re-marks every book that holds the name, and several books hold the same name. Full pipeline page →
₹5,000-6,000 Cr at $5-6bn: below the $7.5bn private peak; the bellwether print for every fintech mark
$7bn last mark (CalPERS-led); domestic-ownership restructuring done: quick-commerce economics on trial
HR SaaS; 3one4 already exited at 58x into the KKR round: listed comp for SaaS books
Triple cross-hold: the most contested realisation event in the cohort
Construction materials; Nexus's next big OFS candidate
No OFS: holders locked to post-listing sales; >$1.4bn already realised in 2019
Z47 running ~$200M part-stake sale at ~$5bn; $750M-1bn issue reported at $6-9bn
Fireside sells ₹150 Cr in OFS: the D2C shelf’s benchmark print
₹1,500-2,000 Cr; A91 diluting below 20% to avoid promoter classification
Bessemer holds >26%: the fintech-infra benchmark print
~$15bn valuation; Tiger and Microsoft exit fully: the highest-stakes pending fintech print
SVF2 re-entered ~$700M in 2021; the e-commerce benchmark listing
Middle-India lending's first big public print
Valuation compressed from peak; test of B2B commerce marks
The capital graph · who moves together, who funds whom
Two computed views: firm pairs whose tracked books overlap most (co-investment gravity), and the institutions anchoring multiple tracked franchises (the LP trust map). Both derived from position books and disclosed fund anchors (GW estimate).
From publicly named fund anchors only: undisclosed LP bases (most franchises) are absent, not empty.
How the GP Score works
Unicorn/soonicorn density, up-round momentum, loss ratio in the tracked book.
IPOs, M&A and secondary sales actually returning cash (DPI signals): the dimension Indian VC is graded hardest on post-2024.
Alignment of the current book and 2025-26 cheques with Gravitywell sector outlooks and the capital cycle.
Fund cadence, dry powder, discipline of deployment pace against the cycle.
Team continuity, LP re-up evidence, succession and spin-out risk.
The GW GP Score is a Gravitywell research opinion (0-100, mapped to the same G1-G6 ladder as our ratings), built from five weighted factors scored on public evidence: portfolio quality (25%), exit realisation (30%), sector positioning (15%), capital velocity (15%) and franchise stability (15%). Fund-level IRR/DPI/TVPI are not public in India; where we cite performance it is either a reported figure (sourced) or a labelled GW estimate band. Position lists are reconstructed from public disclosures and are representative, not exhaustive; ownership stakes are not shown because they are not reliably public. Read the full methodology →
Sourcing. Every figure is sourced and dated. We tier provenance: Primary (official, regulatory, exchange or company filings), Secondary (tier-1 industry research and reputable media), and GW estimate (our own reconstruction or opinion, labelled, never presented as external fact). We prefer primary where it exists, reconcile divergent prints to cited ranges, and hold every number point-in-time: dated, and never silently restated; revisions publish as dated changes.
Fact vs opinion. Facts vs opinion: market sizes, official prints, prices, named deals and agency ratings are sourced facts (Primary/Secondary). Scores, grades, purity weights, scenario paths and indicative sparkline points are Gravitywell's analytical opinion (GW estimate): labelled, not presented as external data.
GW GP Scores are research opinions, not investment advice, not a solicitation, and not an assessment under any SEBI regulation. Dossiers are compiled from public sources believed reliable; firms named did not participate and figures marked E are Gravitywell estimates. Point-in-time: dated to the vintage shown and never silently restated.
The private capital files, refreshed monthly.
New positions, re-ratings and GP Score moves, as they publish.